Travere Therapeutics Inc.

19.75
-1.65 (-7.71%)
At close: Mar 03, 2025, 3:59 PM
19.80
0.28%
After-hours: Mar 03, 2025, 04:05 PM EST

Travere Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08
Cash & Equivalents 58.53M 58.18M 61.69M 165.75M 84.77M 62.44M 102.87M 99.39M 41M 37.8M 18.2M 6M 11.39K 3.91K 3.96K n/a 4.77K
Short-Term Investments 312.17M 508.68M 388.56M 387.13M 276.82M 336.09M 368.67M 201.24M 214.87M 191.8M 9.56M 132.99K n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a 15M -16.81M -6.42M 21.25M -140.81M -2.6B n/a n/a n/a n/a n/a
Other Long-Term Assets 53.82M 42.16M 11.06M 11.07M 33.49M 14.71M -25M 5.56M 7.36M 2M 1.93M 40K 137.55K n/a n/a n/a n/a
Receivables 27.12M 21.18M 16.65M 15.91M 33.07M 18.05M 14.49M 13.87M 65.36M 59.31M 7.96M n/a n/a n/a n/a n/a n/a
Inventory 6.2M 9.41M 6.92M 7.31M 7.61M 6.08M 5.62M 5.35M 2.83M 2.54M 800.51K n/a n/a n/a n/a n/a n/a
Other Current Assets 12.69M 19.34M 15.02M 6.72M 8.14M 7.8M 4.03M 8.8M 8.29M 10.48M 813.36K 1.37M 21.83K n/a n/a n/a n/a
Total Current Assets 416.7M 616.77M 486.44M 582.83M 410.41M 429.06M 495.68M 325.81M 332.35M 301.93M 37.33M 7.5M 33.22K 3.91K 3.96K n/a 4.77K
Property-Plant & Equipment 19.63M 25.54M 30.05M 34.3M 9.42M 2.89M 3.15M 3.23M 2.59M 428K 670.8K 127.43K 23.79K n/a n/a n/a n/a
Goodwill & Intangibles 103.97M 104.44M 145.04M 148.44M 154.13M 158.14M 187.63M 185.75M 182.98M 162.47M 95.2M 12.59M 2.2M n/a n/a n/a n/a
Total Long-Term Assets 177.42M 172.14M 186.15M 193.81M 197.03M 175.74M 213.48M 194.54M 192.93M 210.47M 98.14M 13M 2.36M n/a n/a n/a n/a
Total Assets 594.13M 788.91M 672.59M 776.63M 607.44M 604.8M 709.16M 520.35M 525.28M 512.4M 135.47M 20.5M 2.39M 3.91K 3.96K n/a 4.77K
Account Payables 23.53M 41.67M 17.29M 15.14M 12.13M 26.61M 6.95M 18.94M 7.52M 7.64M 7.12M 3.55M 1.02M 750.00 750.00 n/a 750.00
Deferred Revenue 2.81M 7.1M 11.98M 16.27M -357K -2.61M 49.7M n/a n/a n/a 28.88M n/a 2.49M n/a n/a n/a n/a
Short-Term Debt 74.08M 4.91M 8.87M 7.82M 357K n/a 22.46M n/a n/a n/a 40.49M n/a 884.76K 25K 25K n/a 4.17K
Other Current Liabilities 100.32M 124.23M 104.03M 84.86M 80.17M 68.83M 75.21M 66.73M 75.74M 79.34M 59.93M 33.01M 3.89M 41.24K 38.46K n/a 28.94K
Total Current Liabilities 200.75M 177.91M 142.16M 124.09M 92.66M 95.45M 104.62M 85.67M 83.26M 85.8M 107.54M 35.21M 5.8M 66.99K 64.21K n/a 33.86K
Long-Term Debt 327.5M 399.88M 430.56M 258.08M 243.68M 204.86M 195.09M 45.08M 44.42M 43.77M 43.29M n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities 6.8M 8.48M 46.08M 71.98M 59.89M 83.29M 91.19M 96.47M 83.41M 81.55M 21.9M 1M n/a n/a n/a n/a n/a
Total Long-Term Liabilities 334.3M 410.19M 487.57M 350.43M 303.57M 288.15M 286.29M 141.54M 134.25M 126.63M 65.18M 3.6M 1.91M n/a 25.75K n/a n/a
Total Liabilities 535.05M 588.1M 629.73M 474.52M 396.23M 383.6M 390.91M 227.21M 217.51M 212.43M 172.72M 38.81M 5.8M 66.99K 64.21K n/a 33.86K
Total Debt 401.58M 404.78M 407.49M 261.99M 215.34M 204.86M 217.55M 45.08M 44.42M 43.9M 83.77M n/a 884.76K 25K 25K n/a 4.17K
Common Stock 9K 7K 6K 6K 5K 4K 4K 4K 4K 4K 2.64K 1.85K 895.00 11.00 11.00 n/a n/a
Retained Earnings -1.45B -1.13B -1.01B -765.97M -585.88M -416.44M -270.02M -177.66M -113.06M -65.15M -179.17M -67.44M -33.61M -136.08K -121.26K n/a -70.26K
Comprehensive Income -80K -1.46M -2.91M -562K -902K 726K -1.53M -1.01M -490K -682K 4.29M -109.99K n/a n/a n/a n/a n/a
Shareholders Equity 59.08M 200.81M 42.85M 302.11M 211.21M 221.2M 318.25M 293.13M 307.77M 299.97M -37.25M -18.31M -3.41M -63.08K -60.26K n/a 1.00
Total Investments 312.17M 508.68M 388.56M 387.13M 276.82M 336.09M 383.67M 201.24M 214.87M 191.8M 9.56M 132.99K n/a n/a n/a n/a n/a